- Previous Close
10.12 - Open
10.06 - Bid 9.75 x --
- Ask 11.06 x --
- Day's Range
9.89 - 10.80 - 52 Week Range
8.10 - 17.80 - Volume
149,023 - Avg. Volume
55,893 - Market Cap (intraday)
433.176M - Beta (5Y Monthly) 0.76
- PE Ratio (TTM)
-- - EPS (TTM)
-0.05 - Earnings Date --
- Forward Dividend & Yield 0.50 (4.71%)
- Ex-Dividend Date Apr 26, 2024
- 1y Target Est
25.00
medmix AG designs, produces, and sells high-precision devices and services for the healthcare, consumer, and industrial end markets worldwide. The company operates through Dental, Drug Delivery, Surgery, Industry, and Beauty segments. The company offers dental products, including mixing tips, dispensers, needles, accessories, and service solutions for various applications, such as prosthetics, adhesives, restoratives, prevention, esthetics and endodontics; drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases; and mixing and delivery devices which are used to inject bone tissue, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. It also produces and markets dispensers, mixing tips, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics assembly, infrastructure, and DIY industries; and micro-brushes used for the application of makeup treatments, such as lash & brow serum or spot correctors, as well as for the application of skincare treatments, such as anti-aging treatments. It offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. The company was founded in 1922 and is based in Baar, Switzerland.
www.medmix.swiss2,695
Full Time Employees
December 31
Fiscal Year Ends
Sector
Specialty Industrial Machinery
Industry
Recent News: MEDX.SW
View MorePerformance Overview: MEDX.SW
Trailing total returns as of 1/15/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MEDX.SW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MEDX.SW
View MoreValuation Measures
Market Cap
412.78M
Enterprise Value
635.98M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.93
Price/Book (mrq)
0.90
Enterprise Value/Revenue
1.33
Enterprise Value/EBITDA
8.56
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.37%
Return on Assets (ttm)
1.03%
Return on Equity (ttm)
-0.21%
Revenue (ttm)
479.7M
Net Income Avi to Common (ttm)
-1.8M
Diluted EPS (ttm)
-0.05
Balance Sheet and Cash Flow
Total Cash (mrq)
140.7M
Total Debt/Equity (mrq)
77.34%
Levered Free Cash Flow (ttm)
37.14M